GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹991 Cr | ₹4,348 Cr | ₹3,670 Cr | ₹4,687 Cr | ₹4,869 Cr |
What is the latest Total Debt ratio of GLENMARK PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2024 | ₹991 Cr |
Mar2023 | ₹4,348 Cr |
Mar2022 | ₹3,670 Cr |
Mar2021 | ₹4,687 Cr |
Mar2020 | ₹4,869 Cr |
How is Total Debt of GLENMARK PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹991 Cr | -77.22 | |
Mar2023 | ₹4,348 Cr | 18.46 | |
Mar2022 | ₹3,670 Cr | -21.70 | |
Mar2021 | ₹4,687 Cr | -3.72 | |
Mar2020 | ₹4,869 Cr | - |
Compare Total Debt of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹54,598.6 Cr | -0.4% | -9.6% | 15.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,594.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,722.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹127,508.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,225.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -0.4% |
-9.6% |
15.2% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses